Referencia

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10626-31. Epub 2010 May 24.

Autores

Vanessa Núñeza,1, Daniel Alamedaa,1, Daniel Ricoa,2, Rubén Motab, Pilar Gonzalob, Marta Cedenillaa, Thierry Fischerc, Lisardo Boscád, Christopher K. Glasse, Alicia G. Arroyob, and Mercedes Ricotea,3 Departments of aRegenerative Cardiology and bVascular Biology and Inflammation, Centro Nacional de Investigaciones Cardiovasculares, Madrid 28029, Spain; cDepartment of Immunology and Oncology, Centro Nacional de Biotecnología, Madrid 28049, Spain; dInstituto de Investigaciones Biomédicas “Alberto Sols” (CSIC-UAM), Madrid 28029, Spain; and eDepartment of Medicine, Department of Cellular and Molecular Medicine, University of California,La Jolla, CA 92093 1V.N. and D.A. contributed equally to this work. 2Present address: Structural Biology and Biocomputing Programme, Centro Nacional de Investigaciones Oncológicas, Madrid 28029, Spain. 3To whom correspondence should be addressed. E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it..

Resumen

En nuestro trabajo describimos el papel del receptor X de retinoides (RXR) en la función de los macrófagos durante procesos inflamatorios. RXR es miembro de la superfamilia de los receptores nucleares que son factores de transcripción activados por ligando. Para estudiar la función de RXR en macrófagos generamos un ratón knock-out para RXRα específico de la línea mieloide. Dichos ratones mostraron una disminución en la migración leucocitaria al foco de inflamación en modelos de peritonitis estéril y un incremento en la supervivencia en modelos de sepsis. Todo ello se correlacionó con una reducción en los niveles de las quimioquinas pro-inflamatorias CCL6 y CCL9. Además demostramos que estas quimioquinas están reguladas transcripcionalmente por RXR como homodimero. Nuestros resultados sugieren que RXR es una posible diana terapéutica para el tratamiento de enfermedades inflamatorias.

Descripción

Imagen artículo Julio

REFERENCIA DEL GRUPO Y/O INVESTIGADOR
Los receptores nucleares constituyen una superfamilia de factores de transcripción dependientes de ligando que regulan diferentes aspectos del crecimiento, el desarrollo y la homeostasis. Una de las principales cuestiones en el campo de los receptores nucleares es el descubrimiento de los mecanismos moleculares que median la activación y represión de los genes diana de estos receptores. El objetivo central del laboratorio de la Dra. Mercedes Ricote es elucidar los programas transcripcionales por los cuales estos receptores regulan la expresión génica en macrófagos y como estos patrones de expresión específicos podrían ser modulados para prevenir el desarrollo de enfermedades humanas, tales como obesidad, diabetes y enfermedades cardiovasculares. Para llevar a cabo estos estudios se utiliza una combinación de técnicas de biología molecular/celular, genómica, modelos animales in vivo, específicamente animales knockouts condicionales en macrófagos y tecnología de microarrays. En el trabajo recientemente publicado en Proceedings of the National Academy of Science se establece que el receptor X de retinoides (RXR) desempeña un papel importante en la respuesta innata. El resultado de nuestros experimentos demuestra que RXR es una potencial diana terapéutica para el tratamiento y prevención de la sepsis así como de otras enfermedades inflamatorias crónicas. Otras líneas de investigación del laboratorio exploran el papel de los receptores nucleares en las bases moleculares de la resistencia a la insulina y la aterosclerosis. Mercedes Ricote es investigadora del Centro Nacional de Investigaciones Cardiovasculares (CNIC).

Para ver el artículo completo, pulse aquí

Did you publish an interesting article recently?

Send it through our application form and we will contact you. Age limit: 32.

The selected articles will participate at the Award to the best article of young people of the SEBBM which will be given during SEBBM conference, that will take place at Spain (free registration, travel and accommodation).

More articles of the month

Macrophages promote endothelial-to-mesenchymal transition via MT1-MMP/TGFß after myocardial infarction

01-12-2020

Macrophages (Mφs) produce factors that participate in cardiac repair and remodeling after myocardial infarction (MI); however, how these factors crosstalk with other cell types mediating repair is not fully understood...

Read more

Cell identity and nucleo-mitochondrial genetic context modulate OXPHOS performance and determine somatic heteroplasmy dynamics

30-10-2020

Heteroplasmy, multiple variants of mitochondrial DNA (mtDNA) in the same cytoplasm, may be naturally generated by mutations but is counteracted by a genetic mtDNA bottleneck during oocyte development. Engineered heteroplasmic...

Read more

Mechanisms of autoregulation of C3G, activator of the GTPase Rap1, and its catalytic deregulation in lymphomas

01-10-2020

C3G is a guanine nucleotide exchange factor (GEF) that regulates cell adhesion and migration by activating the GTPase Rap1. The GEF activity of C3G is stimulated by the adaptor proteins...

Read more

Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia

31-08-2020

The reciprocal translocation t(12;21)(p13;q22)[ETV6/RUNX1] is the most frequent chromosomal rearrangement in pediatric B-cell acute lymphoblastic leukemia(B-ALL). Long non-coding RNAs (lncRNAs) play important roles in numerous diseases and they represent an...

Read more

Evaluation of different approaches used to study membrane permeabilization by actinoporins on model lipid vesicles

30-07-2020

Release of aqueous contents from model lipid vesicles has been a standard procedure to evaluate pore formation efficiency by actinoporins, such as sticholysin II (StnII), for the last few decades...

Read more

ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity

01-07-2020

Adenosine deaminases acting on RNA (ADARs) convert adenosine to inosine in double-stranded RNA. A-to-I editing of RNA is a widespread posttranscriptional process that has recently emerged as an important mechanism...

Read more

Sarcoplasmic reticulum Ca2+ decreases with age and correlates with the decline in muscle function in Drosophila

29-05-2020

Sarcopenia, the loss of muscle mass and strength associated with age, has been linked to impairment of the cytosolic Ca2+ peak that triggers muscle contraction, but mechanistic details remain unknown...

Read more

Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase

30-04-2020

Core-fucosylation is an essential biological modification by which a fucose is transferred from GDP-β-L-fucose to the innermost N-acetylglucosamine residue of N-linked glycans. A single human enzyme α1,6-fucosyltransferase (FUT8) is the...

Read more

Molecular basis for fibroblast growth factor 23 O-glycosylation by GalNAc-T3

31-03-2020

Polypeptide GalNAc-transferase T3 (GalNAc-T3) regulates fibroblast growth factor 23 (FGF23) by O-glycosylating Thr178 in a furin proprotein processing motif RHT 178R ↓S. FGF23 regulates phosphate homeostasis and deficiency in GALNT3...

Read more

Identification of distinct maturation steps involved in human 40S ribosomal subunit biosynthesis

29-02-2020

Technical problems intrinsic to the purification of preribosome intermediates have limited our understanding of ribosome biosynthesis in humans. Addressing this issue is important given the implication of this biological process...

Read more

Protector Members